Search research articles
Contact Us
Filters
Showing results (131-140 of 144) with videos related to
Page
of 15
Sort By:
Frontiers in Psychiatry
|
June 3, 2022
Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
Hikaru Hori, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Psychiatry and Clinical Neurosciences
|
October 10, 2022
Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysis
Takashi Tsuboi, Yoshikazu Takaesu, Naomi Hasegawa, et al.
Annals of General Psychiatry
|
December 25, 2022
The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project
Yoshitaka Kyou, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports
|
October 18, 2022
Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia"
Ken Inada, Kentaro Fukumoto, Naomi Hasegawa, et al.
Journal of Clinical Psychopharmacology
|
October 4, 2022
Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia
Tsuyoshi Okada, Hikaru Hori, Naomi Hasegawa, et al.
Psychiatry and Clinical Neurosciences
|
September 9, 2023
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study
Naomi Hasegawa, Yuka Yasuda, Norio Yasui-Furukori, et al.
Neuropsychopharmacology Reports
|
February 26, 2025
Proposal for a Novel Classification of Patients With Enlarged Ventricles and Cognitive Impairment Based on Data-Driven Analysis of Neuroimaging Results in Patients With Psychiatric Disorders
Yuka Yasuda, Satsuki Ito, Junya Matsumoto, et al.
Neuropsychopharmacology Reports
|
March 10, 2022
Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry
Kazuyoshi Ogasawara, Shusuke Numata, Naomi Hasegawa, et al.
Bjpsych Open
|
April 21, 2022
A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project
Hisashi Yamada, Mikuni Motoyama, Naomi Hasegawa, et al.
Psychiatry and Clinical Neurosciences
|
August 23, 2019
Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study
Yoshikazu Takaesu, Koichiro Watanabe, Shusuke Numata, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 144) with videos related to
Sort By:
Page
of 15
Frontiers in Psychiatry
|
June 3, 2022
Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
Hikaru Hori, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Psychiatry and Clinical Neurosciences
|
October 10, 2022
Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysis
Takashi Tsuboi, Yoshikazu Takaesu, Naomi Hasegawa, et al.
Annals of General Psychiatry
|
December 25, 2022
The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project
Yoshitaka Kyou, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports
|
October 18, 2022
Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia"
Ken Inada, Kentaro Fukumoto, Naomi Hasegawa, et al.
Journal of Clinical Psychopharmacology
|
October 4, 2022
Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia
Tsuyoshi Okada, Hikaru Hori, Naomi Hasegawa, et al.
Psychiatry and Clinical Neurosciences
|
September 9, 2023
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study
Naomi Hasegawa, Yuka Yasuda, Norio Yasui-Furukori, et al.
Neuropsychopharmacology Reports
|
February 26, 2025
Proposal for a Novel Classification of Patients With Enlarged Ventricles and Cognitive Impairment Based on Data-Driven Analysis of Neuroimaging Results in Patients With Psychiatric Disorders
Yuka Yasuda, Satsuki Ito, Junya Matsumoto, et al.
Neuropsychopharmacology Reports
|
March 10, 2022
Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry
Kazuyoshi Ogasawara, Shusuke Numata, Naomi Hasegawa, et al.
Bjpsych Open
|
April 21, 2022
A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project
Hisashi Yamada, Mikuni Motoyama, Naomi Hasegawa, et al.
Psychiatry and Clinical Neurosciences
|
August 23, 2019
Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study
Yoshikazu Takaesu, Koichiro Watanabe, Shusuke Numata, et al.
Page
of 15